NEW YORK (GenomeWeb News) – An affiliate of the DNA Medicine Institute plans to raise $1 million through a private stock offering, the Cambridge, Mass.-based firm disclosed in a document filed with the US Securities and Exchange Commission.
The company did not disclose how it will use proceeds from the offering, but said that it is not being made in connection with a business combination transaction such as a merger or acquisition.